Adverum Biotechnologies, Inc. (ADVM): Price and Financial Metrics

Adverum Biotechnologies, Inc. (ADVM): $6.17

0.08 (-1.28%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

Add ADVM to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#152 of 332

in industry

ADVM Price/Volume Stats

Current price $6.17 52-week high $29.70
Prev. close $6.25 52-week low $6.00
Day low $6.00 Volume 221,400
Day high $6.34 Avg. volume 277,284
50-day MA $7.45 Dividend yield N/A
200-day MA $10.00 Market Cap 128.35M

ADVM Stock Price Chart Interactive Chart >


Adverum Biotechnologies, Inc. (ADVM) Company Bio


Adverum Biotechnologies, Inc., a gene therapy company, engages in discovering and developing novel medicines that offer therapeutic benefit to patients suffering from chronic or debilitating disease. It primary focuses on developing AVA-101, which is in a Phase IIa trial for the treatment of wet age-related macular degeneration (AMD). The company was founded in 2006 and is based in Menlo Park, California.


ADVM Latest News Stream


Event/Time News Detail
Loading, please wait...

ADVM Latest Social Stream


Loading social stream, please wait...

View Full ADVM Social Stream

ADVM Price Returns

1-mo -24.20%
3-mo -15.71%
6-mo -18.82%
1-year -26.57%
3-year -68.52%
5-year -93.74%
YTD -18.04%
2023 29.91%
2022 -67.07%
2021 -83.76%
2020 -5.90%
2019 265.71%

Continue Researching ADVM

Here are a few links from around the web to help you further your research on Adverum Biotechnologies Inc's stock as an investment opportunity:

Adverum Biotechnologies Inc (ADVM) Stock Price | Nasdaq
Adverum Biotechnologies Inc (ADVM) Stock Quote, History and News - Yahoo Finance
Adverum Biotechnologies Inc (ADVM) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!